BSX · 10-Q · 2026Q3 · Full report

Restructuring and Cost Savings

BOSTON SCIENTIFIC CORP · 2026-11-02 · Importance 58 · Surprise 42 · In source text

On July 21, 2026, the Board approved and Boston Scientific committed to a new global restructuring program intended to improve cost efficiency and align resources with strategic priorities. The 2026 Restructuring Plan is expected to generate total pretax charges of approximately $700 million to $800 million, including $600 million to $700 million in future cash outlays. As benefits are realized, the plan is expected to reduce gross annual pretax expenses by approximately $500 million, with some savings reinvested in strategic growth initiatives. The company recorded $102 million of related costs from the plan’s inception through September 30, 2026.

Key facts

• On July 21, 2026, the board approved and Boston Scientific committed to a new global restructuring plan expected to incur $700 million to $800 million of pretax charges, including $600 million to $700 million of future cash outlays, and reduce gross annual pretax expenses by approximately $500 million as benefits are realized. source
• The 2023 Restructuring Plan, begun in February 2023 and expanded in July 2025, was fully completed in the second quarter of 2026; related costs totaled $748 million since inception. source
• Boston Scientific had recorded $102 million of costs for the 2026 Restructuring Plan since its inception. source
• Boston Scientific expects to reinvest a portion of the 2026 Restructuring Plan savings in strategic growth initiatives. source

Impact estimates